Four Medical Societies Mapped Women’s Heart Risk From First Period Through Menopause

CATEGORY: WOMEN’S HEALTH

Heart disease kills more than 400,000 American women every year. That’s more than breast cancer, lung cancer and chronic lung disease combined. Yet only about four in ten women name it as their biggest health threat. This week, the American Heart Association, the American Academy of Pediatrics, the American College of Obstetricians and Gynecologists and the Society for Maternal-Fetal Medicine published their first joint guidance on women’s heart health.¹ The three coordinated papers in Circulation treat a woman’s heart risk as a story that begins in childhood, not at retirement.

Four Life Stages, With Pregnancy as the Stress Test

The framework divides a female life into four stages: perimenarche (roughly ages 8 to 15, the years around the first period), ovarian cycling (about 15 to 44), perimenopause (about 45 to 51) and postmenopause. Each stage carries its own warning signs and its own openings to act early. Pregnancy sits apart, because it can arrive in any of the middle stages, and the papers describe it as a natural stress test for the heart. When preeclampsia (dangerous high blood pressure in pregnancy), gestational diabetes (diabetes that first appears during pregnancy) or a preterm birth shows up, the body has revealed something about its cardiovascular future. The guidance says that information should follow a woman well past the delivery room. The stakes are not small: cardiovascular conditions now cause more than a third of U.S. maternal deaths, and heart disease is the leading medical cause of death in pregnancy.¹

Heavy or Irregular Periods Join the Vital Signs

One concrete change runs through the package. The papers treat menstrual patterns as a female-specific vital sign, something for clinicians to track the way they track blood pressure.² Heavy or irregular bleeding may signal cardiovascular risk. That includes the common hormonal condition long called polycystic ovary syndrome, which the papers refer to by its new name, polyendocrine metabolic ovarian syndrome, a label meant to reflect how far beyond the ovaries it reaches. The guidance also names anxiety and depression, both more common in women, as conditions that can worsen heart health over time.² And it wants a woman’s pregnancy history folded into everyday risk decisions, something the 2026 national cholesterol guideline has already begun to do by counting pregnancy-related factors.²

Most of the Damage Comes Late, and Most of It Is Preventable

Postmenopause can span up to 40% of a woman’s lifetime. It’s the stage where most heart attacks, strokes and heart failure events happen, and the societies report that more than 80% of them are preventable with early action.¹ The trend line explains their urgency. If nothing changes, the share of U.S. women aged 20 and older with high blood pressure is projected to rise from about 49% in 2020 to 59% by 2050. The papers point clinicians to the sex-specific PREVENT equations, which estimate 10-year and 30-year risk, and call for a national network of Comprehensive Centers of Excellence for Women’s Cardiovascular Care built on clinical care, training, research and community engagement.³ They also flag one gap to close first: only about 60% of women who have high-blood-pressure complications in pregnancy get follow-up care within six months of delivery. As writing-group chair Dr. Sadiya Khan put it, “Heart health cannot be understood by looking at the heart alone.”

Key Takeaways

• Four major medical societies published their first coordinated, female-specific framework for preventing and managing heart disease, spanning girlhood through the decades after menopause.
• Pregnancy complications such as preeclampsia, gestational diabetes and preterm birth mark higher future cardiovascular risk, and cardiovascular conditions now cause over a third of U.S. maternal deaths.
• The societies report that more than 80% of the heart attacks, strokes and heart failure events of the postmenopausal years are preventable with early action.

References

1. Khan SS, Grobman WA, Perak AM, et al. A Female-Specific Life Course Approach to the Prevention and Management of Cardiovascular Disease: A Presidential Advisory From the American Heart Association, American Academy of Pediatrics, American College of Obstetricians and Gynecologists, and Society for Maternal-Fetal Medicine. Circulation. 2026:CIR.0000000000001483. link
2. Khan SS, Grobman WA, Angell SY, et al. Consensus Guidance for the Female-Specific Prevention and Management of Cardiovascular Disease: A Scientific Statement From the American Heart Association, American Academy of Pediatrics, American College of Obstetricians and Gynecologists, and Society for Maternal-Fetal Medicine. Circulation. 2026:CIR.0000000000001482. link
3. Cameron NA, Khan SS, Bairey Merz CN, et al. Comprehensive Centers of Excellence for Women’s Cardiovascular Care: A Science Advisory From the American Heart Association, American Academy of Pediatrics, American College of Obstetricians and Gynecologists, and Society for Maternal-Fetal Medicine. Circulation. 2026:CIR.0000000000001481. link